TY - JOUR
T1 - Noncovalent Peptide Stapling Using Alpha-Methyl-l-Phenylalanine for α-Helical Peptidomimetics
AU - Bathgate, Ross A.D.
AU - Praveen, Praveen
AU - Sethi, Ashish
AU - Furuya, Werner I.
AU - Dhingra, Rishi R.
AU - Kocan, Martina
AU - Ou, Qinghao
AU - Valkovic, Adam L.
AU - Gil-Miravet, Isis
AU - Navarro-Sánchez, Mónica
AU - Olucha-Bordonau, Francisco E.
AU - Gundlach, Andrew L.
AU - Rosengren, K. Johan
AU - Gooley, Paul R.
AU - Dutschmann, Mathias
AU - Hossain, Mohammed Akhter
N1 - Publisher Copyright:
© 2023 American Chemical Society.
PY - 2023/9/20
Y1 - 2023/9/20
N2 - Peptides and peptidomimetics are attractive drug candidates because of their high target specificity and low-toxicity profiles. Developing peptidomimetics using hydrocarbon (HC)-stapling or other stapling strategies has gained momentum because of their high stability and resistance to proteases; however, they have limitations. Here, we take advantage of the α-methyl group and an aromatic phenyl ring in a unique unnatural amino acid, α-methyl-l-phenylalanine (αF), and propose a novel, noncovalent stapling strategy to stabilize peptides. We utilized this strategy to create an α-helical B-chain mimetic of a complex insulin-like peptide, human relaxin-3 (H3 relaxin). Our comprehensive data set (in vitro, ex vivo, and in vivo) confirmed that the new high-yielding B-chain mimetic, H3B10-27(13/17αF), is remarkably stable in serum and fully mimics the biological function of H3 relaxin. H3B10-27(13/17αF) is an excellent scaffold for further development as a drug lead and an important tool to decipher the physiological functions of the neuropeptide G protein-coupled receptor, RXFP3.
AB - Peptides and peptidomimetics are attractive drug candidates because of their high target specificity and low-toxicity profiles. Developing peptidomimetics using hydrocarbon (HC)-stapling or other stapling strategies has gained momentum because of their high stability and resistance to proteases; however, they have limitations. Here, we take advantage of the α-methyl group and an aromatic phenyl ring in a unique unnatural amino acid, α-methyl-l-phenylalanine (αF), and propose a novel, noncovalent stapling strategy to stabilize peptides. We utilized this strategy to create an α-helical B-chain mimetic of a complex insulin-like peptide, human relaxin-3 (H3 relaxin). Our comprehensive data set (in vitro, ex vivo, and in vivo) confirmed that the new high-yielding B-chain mimetic, H3B10-27(13/17αF), is remarkably stable in serum and fully mimics the biological function of H3 relaxin. H3B10-27(13/17αF) is an excellent scaffold for further development as a drug lead and an important tool to decipher the physiological functions of the neuropeptide G protein-coupled receptor, RXFP3.
UR - https://www.scopus.com/pages/publications/85165694783
U2 - 10.1021/jacs.3c02743
DO - 10.1021/jacs.3c02743
M3 - Article
C2 - 37439676
AN - SCOPUS:85165694783
SN - 0002-7863
VL - 145
SP - 20242
EP - 20247
JO - Journal of the American Chemical Society
JF - Journal of the American Chemical Society
IS - 37
ER -